ASP Isotopes' General Counsel Filed to Sell $622,000

🔴 Insider Activity Score: 93/100

Donald George Ainscow, EVP, General Counsel, and Secretary of ASP Isotopes, filed a Form 144 on June 30, 2026 registering the proposed sale of 100,000 common shares at a $6.22 per share closing baseline via Citigroup Global Markets for approximately $622,000 — sourced from original private placement shares acquired with cash on September 29, 2021. The filing arrives closely following Ainscow's receipt of a 400,000-share long-term incentive award on May 28, 2026, which had elevated his direct holdings to a 900,000-share peak. Following the proposed distribution, Ainscow's direct footprint settles to 800,000 shares. As a Form 144 proposed ceiling rather than a completed Form 4 execution, the $622,000 has not been realized. Citigroup has the mandate.

The September 2021 Private Placement Vintage: Five-Year Capital Unlock

The underlying equity tracing to a September 29, 2021 cash private placement is the specific compensation vintage detail that contextualizes the proposed distribution — not a routine RSU vesting or option exercise but original private placement shares purchased with personal cash nearly five years before the Form 144 filing.

Private placement shares acquired in September 2021 carry the specific lock-up and holding period characteristics that Rule 144 governs — a restricted securities holding that becomes freely salable after the applicable holding period expires, subject to volume limitations, manner-of-sale requirements, and the Form 144 filing that Ainscow has now submitted. The five-year hold from September 2021 to mid-2026 represents the full private placement investment cycle — the GC deploying personal cash at the company's early private stage and now accessing liquidity through the Rule 144 distribution framework.

The $6.22 per share proposed baseline against a September 2021 private placement price — which at an early-stage isotope enrichment company's private round pricing was almost certainly a fraction of the current $6.22 level — represents the accumulated appreciation of the private placement investment across five years of ASP Isotopes' commercial development.

The May 28 Incentive Award Context: Fresh Grant, Old Shares Proposed

The 400,000-share long-term incentive award received on May 28, 2026 — elevating Ainscow's direct holdings to a 900,000-share peak before the proposed distribution — provides the specific near-term compensation context that makes the 100,000-share private placement liquidity event analytically bounded.

An executive who received 400,000 new incentive shares thirty-three days before filing a Form 144 to distribute 100,000 old private placement shares is not reducing his net Spyre alignment. He is managing the specific liquidity mechanics of a five-year-old private placement investment while retaining both the full incentive award and a substantial residual position. The net effect: 400,000 new incentive shares received, 100,000 old private placement shares proposed for distribution, 800,000 shares retained — a net position increase of 300,000 shares across the thirty-three day window.

The Citigroup Mandate and the $6.22 Reference

Citigroup Global Markets as the designated execution agent reflects the institutional distribution infrastructure appropriate for a specialized isotope enrichment company's GC-level Form 144 block — a broker with the sector-specific relationships to locate natural buyers for a $622,000 block in a niche materials science company.

The $6.22 closing baseline reflects the current market pricing of ASP Isotopes' uranium enrichment and medical isotope production platform — a specialized materials company whose commercial trajectory in nuclear fuel production and medical radioisotope supply has defined the specific valuation environment that the September 2021 private placement has appreciated into.

About ASP Isotopes Inc.

ASP Isotopes Inc. is a specialized isotope enrichment company developing advanced separation technology for uranium enrichment and medical isotope production. EVP, General Counsel, and Secretary Donald Ainscow holds 800,000 direct common shares following the May 28 receipt of 400,000 incentive shares and the pending Form 144 proposed distribution of 100,000 September 2021 private placement shares via Citigroup Global Markets. ASP Isotopes trades on the Nasdaq under the ticker ASPI.

How to Think About This

Ainscow's Form 144 private placement liquidity event scores 93/100 — the alarm-management calibration for a GC-level proposed sale at a specialized isotope enrichment company, with the five-year private placement vintage contextualizing the mechanism and the concurrent 400,000-share incentive award confirming the net alignment is expanding rather than contracting.

The September 2021 private placement explains the instrument. The May 28 incentive award explains the net position math. The 800,000 retained shares — including the fresh 400,000-share grant received thirty-three days before the filing — confirm the GC's foundational ASP Isotopes commitment is materially larger today than it was before the proposed distribution.

The Form 144 proposed 100,000 old shares for distribution. The May award delivered 400,000 new ones. The 800,000 retained is the net result.

Consolidated Insider Filings